{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:22:26Z","timestamp":1775881346435,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1038\/leu.2013.196","type":"journal-article","created":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T08:28:36Z","timestamp":1372667316000},"page":"2332-2340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Functional characterization of Foxp3-specific spontaneous immune responses"],"prefix":"10.1038","volume":"27","author":[{"given":"S K","family":"Larsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Munir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Woetmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T M","family":"Fr\u00f8sig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Odum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I M","family":"Svane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J C","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M H","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,1]]},"reference":[{"key":"BFleu2013196_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00281-006-0043-2","volume":"28","author":"S Sakaguchi","year":"2006","unstructured":"Sakaguchi S . Regulatory T cells. Springer Semin Immunopathol 2006; 28: 1\u20132.","journal-title":"Springer Semin Immunopathol"},{"key":"BFleu2013196_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.1160062","volume":"322","author":"K Wing","year":"2008","unstructured":"Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008; 322: 271\u2013275.","journal-title":"Science"},{"key":"BFleu2013196_CR3","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1084\/jem.20080707","volume":"205","author":"X Zhou","year":"2008","unstructured":"Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 2008; 205: 1983\u20131991.","journal-title":"J Exp Med"},{"key":"BFleu2013196_CR4","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1038\/sj.leu.2403972","volume":"19","author":"T Kollgaard","year":"2005","unstructured":"Kollgaard T, Petersen SL, Hadrup SR, Masmas TN, Seremet T, Andersen MH et al. Evidence for involvement of clonally expanded CD8+ T cells in anticancer immune responses in CLL patients following nonmyeloablative conditioning and hematopoietic cell transplantation. Leukemia 2005; 19: 2273\u20132280.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR5","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/leu.2008.29","volume":"22","author":"I Hus","year":"2008","unstructured":"Hus I, Schmitt M, Tabarkiewicz J, Radej S, Wojas K, Bojarska-Junak A et al. Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response. Leukemia 2008; 22: 1007\u20131017.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR6","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","volume":"21","author":"LM Gjerdrum","year":"2007","unstructured":"Gjerdrum LM, Woetmann A, Odum N, Burton CM, Rossen K, Skovgaard GL et al. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Leukemia 2007; 21: 2512\u20132518.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/sj.leu.2404869","volume":"22","author":"K Giannopoulos","year":"2008","unstructured":"Giannopoulos K, Schmitt M, Wlasiuk P, Chen J, Bojarska-Junak A, Kowal M et al. The high frequency of T regulatory cells in patients with B-cell chronic lymphocytic leukemia is diminished through treatment with thalidomide. Leukemia 2008; 22: 222\u2013224.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR8","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/leu.2011.301","volume":"26","author":"P Ame-Thomas","year":"2012","unstructured":"Ame-Thomas P, Le PJ, Yssel H, Caron G, Pangault C, Jean R et al. Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells. Leukemia 2012; 26: 1053\u20131063.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR9","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1158\/0008-5472.CAN-11-3912","volume":"72","author":"DT Le","year":"2012","unstructured":"Le DT, Jaffee EM . Regulatory T-cell modulation using cyclophosphamide in vaccine approaches: a current perspective. Cancer Res 2012; 72: 3439\u20133444.","journal-title":"Cancer Res"},{"key":"BFleu2013196_CR10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/leu.2011.237","volume":"26","author":"T Krejsgaard","year":"2012","unstructured":"Krejsgaard T, Odum N, Geisler C, Wasik MA, Woetmann A . Regulatory T cells and immunodeficiency in mycosis fungoides and Sezary syndrome. Leukemia 2012; 26: 424\u2013432.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR11","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1038\/leu.2008.224","volume":"22","author":"T Krejsgaard","year":"2008","unstructured":"Krejsgaard T, Gjerdrum LM, Ralfkiaer E, Lauenborg B, Eriksen KW, Mathiesen AM et al. Malignant Tregs express low molecular splice forms of FOXP3 in Sezary syndrome. Leukemia 2008; 22: 2230\u20132239.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR12","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/sj.leu.2403965","volume":"19","author":"G Roncador","year":"2005","unstructured":"Roncador G, Garcia JF, Garcia JF, Maestre L, Lucas E, Menarguez J et al. FOXP3, a selective marker for a subset of adult T-cell leukaemia\/lymphoma. Leukemia 2005; 19: 2247\u20132253.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR13","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1038\/jid.2009.175","volume":"129","author":"JB Heid","year":"2009","unstructured":"Heid JB, Schmidt A, Oberle N, Goerdt S, Krammer PH, Suri-Payer E et al. FOXP3+CD25- tumor cells with regulatory function in Sezary syndrome. J Invest Dermatol 2009; 129: 2875\u20132885.","journal-title":"J Invest Dermatol"},{"key":"BFleu2013196_CR14","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/sj.leu.2403628","volume":"19","author":"Y Matsubara","year":"2005","unstructured":"Matsubara Y, Hori T, Morita R, Sakaguchi S, Uchiyama T . Phenotypic and functional relationship between adult T-cell leukemia cells and regulatory T cells. Leukemia 2005; 19: 482\u2013483.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR15","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1038\/sj.leu.2403930","volume":"19","author":"A Van Driessche","year":"2005","unstructured":"Van Driessche A, Gao L, Stauss HJ, Ponsaerts P, Van Bockstaele DR, Berneman ZN et al. Antigen-specific cellular immunotherapy of leukemia. Leukemia 2005; 19: 1863\u20131871.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR16","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/leu.2011.24","volume":"25","author":"A Heine","year":"2011","unstructured":"Heine A, Held SA, Bringmann A, Holderried TA, Brossart P . Immunomodulatory effects of anti-angiogenic drugs. Leukemia 2011; 25: 899\u2013905.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR17","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1158\/1535-7163.MCT-10-0185","volume":"9","author":"R Metz","year":"2010","unstructured":"Metz R, DuHadaway JB, Rust S, Munn DH, Muller AJ, Mautino M et al. Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenase. Mol Cancer Ther 2010; 9: 1864\u20131871.","journal-title":"Mol Cancer Ther"},{"key":"BFleu2013196_CR18","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1172\/JCI25947","volume":"115","author":"J Dannull","year":"2005","unstructured":"Dannull J, Su Z, Rizzieri D, Yang BK, Coleman D, Yancey D et al. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest 2005; 115: 3623\u20133633.","journal-title":"J Clin Invest"},{"key":"BFleu2013196_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-0-387-68969-2_20","volume":"622","author":"BG Barnett","year":"2008","unstructured":"Barnett BG, Ruter J, Kryczek I, Brumlik MJ, Cheng PJ, Daniel BJ et al. Regulatory T cells: a new frontier in cancer immunotherapy. Adv Exp Med Biol 2008; 622: 255\u2013260.","journal-title":"Adv Exp Med Biol"},{"key":"BFleu2013196_CR20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature10673","volume":"480","author":"I Mellman","year":"2011","unstructured":"Mellman I, Coukos G, Dranoff G . Cancer immunotherapy comes of age. Nature 2011; 480: 480\u2013489.","journal-title":"Nature"},{"key":"BFleu2013196_CR21","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00262-012-1266-9","volume":"61","author":"JC Becker","year":"2012","unstructured":"Becker JC, Andersen MH, Hofmeister-Muller V, Wobser M, Frey L, Sandig C et al. Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma. Cancer Immunol Immunother 2012; 61: 2091\u20132103.","journal-title":"Cancer Immunol Immunother"},{"key":"BFleu2013196_CR22","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/nm.2883","volume":"18","author":"S Walter","year":"2012","unstructured":"Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C et al. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med 2012; 18: 1254\u20131261.","journal-title":"Nat Med"},{"key":"BFleu2013196_CR23","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/leu.2009.98","volume":"23","author":"K Giannopoulos","year":"2009","unstructured":"Giannopoulos K, Dmoszynska A, Kowal M, Wasik-Szczepanek E, Bojarska-Junak A, Rolinski J et al. Thalidomide exerts distinct molecular antileukemic effects and combined thalidomide\/fludarabine therapy is clinically effective in high-risk chronic lymphocytic leukemia. Leukemia 2009; 23: 1771\u20131778.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1158\/0008-5472.CAN-06-2903","volume":"67","author":"S Nair","year":"2007","unstructured":"Nair S, Boczkowski D, Fassnacht M, Pisetsky D, Gilboa E . Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. Cancer Res 2007; 67: 371\u2013380.","journal-title":"Cancer Res"},{"key":"BFleu2013196_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0960-9822(95)00011-X","volume":"5","author":"HG Rammensee","year":"1995","unstructured":"Rammensee HG, Falk K, Roetzschke O . MHC molecules as peptide receptors. Curr Biol 1995; 5: 35\u201344.","journal-title":"Curr Biol"},{"key":"BFleu2013196_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0022-1759(97)00182-8","volume":"210","author":"M McCutcheon","year":"1997","unstructured":"McCutcheon M, Wehner N, Wensky A, Kushner M, Doan S, Hsiao L et al. A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. J Immunol Methods 1997; 210: 149\u2013166.","journal-title":"J Immunol Methods"},{"key":"BFleu2013196_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nm1360","volume":"12","author":"M Toebes","year":"2006","unstructured":"Toebes M, Coccoris M, Bins A, Rodenko B, Gomez R, Nieuwkoop NJ et al. Design and use of conditional MHC class I ligands. Nat Med 2006; 12: 246\u2013251.","journal-title":"Nat Med"},{"key":"BFleu2013196_CR28","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.4049\/jimmunol.163.7.3812","volume":"163","author":"MH Andersen","year":"1999","unstructured":"Andersen MH, Bonfill JE, Neisig A, Arsequell G, Sondergaard I, Valencia G et al. Phosphorylated peptides can be transported by TAP molecules presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL. J Immunol 1999; 163: 3812\u20133818.","journal-title":"J Immunol"},{"key":"BFleu2013196_CR29","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1074\/jbc.M606669200","volume":"282","author":"KU Birkenkamp","year":"2007","unstructured":"Birkenkamp KU, Essafi A, van der Vos KE, da CM, Hui RC, Holstege F et al. FOXO3a induces differentiation of Bcr-Abl-transformed cells through transcriptional down-regulation of Id1. J Biol Chem 2007; 282: 2211\u20132220.","journal-title":"J Biol Chem"},{"key":"BFleu2013196_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/sj.leu.2401703","volume":"14","author":"Z Berke","year":"2000","unstructured":"Berke Z, Andersen MH, Pedersen M, Fugger L, Zeuthen J, Haurum JS . Peptides spanning the junctional region of both the abl\/bcr and the bcr\/abl fusion proteins bind common HLA class I molecules. Leukemia 2000; 14: 419\u2013426.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR31","first-page":"2744","volume":"9","author":"J Willers","year":"2003","unstructured":"Willers J, Dummer R, Kempf W, Kundig T, Burg G, Kadin ME . Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand. Clin Cancer Res 2003; 9: 2744\u20132754.","journal-title":"Clin Cancer Res"},{"key":"BFleu2013196_CR32","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/sj.leu.2403743","volume":"19","author":"MH Andersen","year":"2005","unstructured":"Andersen MH, Kvistborg P, Becker JC, thor Straten P . Identification of an HLA-A1 restricted CTL epitope from Mcl-1. Leukemia 2005; 19: 1084\u20131085.","journal-title":"Leukemia"},{"key":"BFleu2013196_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","volume":"281","author":"MR Betts","year":"2003","unstructured":"Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281: 65\u201378.","journal-title":"J Immunol Methods"},{"key":"BFleu2013196_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1479-5876-1-14","volume":"1","author":"K Shafer-Weaver","year":"2003","unstructured":"Shafer-Weaver K, Sayers T, Strobl S, Derby E, Ulderich T, Baseler M et al. The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity. J Transl Med 2003; 1: 14.","journal-title":"J Transl Med"},{"key":"BFleu2013196_CR35","doi-asserted-by":"publisher","first-page":"11903","DOI":"10.1073\/pnas.0801506105","volume":"105","author":"A Liston","year":"2008","unstructured":"Liston A, Nutsch KM, Farr AG, Lund JM, Rasmussen JP, Koni PA et al. Differentiation of regulatory Foxp3+ T cells in the thymic cortex. Proc Natl Acad Sci USA 2008; 105: 11903\u201311908.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2013196_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1600-065X.2008.00637.x","volume":"223","author":"TM Brusko","year":"2008","unstructured":"Brusko TM, Putnam AL, Bluestone JA . Human regulatory T cells: role in autoimmune disease and therapeutic opportunities. Immunol Rev 2008; 223: 371\u2013390.","journal-title":"Immunol Rev"},{"key":"BFleu2013196_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1084\/jem.186.1.65","volume":"186","author":"SR Bennett","year":"1997","unstructured":"Bennett SR, Carbone FR, Karamalis F, Miller JF, Heath WR . Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 1997; 186: 65\u201370.","journal-title":"J Exp Med"},{"key":"BFleu2013196_CR38","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1182\/blood-2010-06-288498","volume":"117","author":"RB Sorensen","year":"2011","unstructured":"Sorensen RB, Hadrup SR, Svane IM, Hjortso MC, Thor SP, Andersen MH . Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators. Blood 2011; 117: 2200\u20132210.","journal-title":"Blood"},{"key":"BFleu2013196_CR39","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1158\/0008-5472.CAN-10-3403","volume":"71","author":"RB Sorensen","year":"2011","unstructured":"Sorensen RB, Kollgaard T, Andersen RS, van den Berg JH, Svane IM, Straten P et al. Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2. Cancer Res 2011; 71: 2038\u20132044.","journal-title":"Cancer Res"},{"key":"BFleu2013196_CR40","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1158\/0008-5472.CAN-12-3507","volume":"73","author":"S Munir","year":"2013","unstructured":"Munir S, Andersen GH, Met O, Donia M, Frosig TM, Larsen SK et al. HLA-restricted cytotoxic T cells that are specific for the immune checkpoint ligand PD-L1 occur with high frequency in cancer patients. Cancer Res 2013; 73: 1674\u20131776.","journal-title":"Cancer Res"},{"key":"BFleu2013196_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/eji.200737462","volume":"37","author":"C Feig","year":"2007","unstructured":"Feig C, Peter ME . How apoptosis got the immune system in shape. Eur J Immunol 2007; 37: 61\u201370.","journal-title":"Eur J Immunol"},{"key":"BFleu2013196_CR42","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S . Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057\u20131061.","journal-title":"Science"},{"key":"BFleu2013196_CR43","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1084\/jem.20050157","volume":"202","author":"X Chang","year":"2005","unstructured":"Chang X, Gao JX, Jiang Q, Wen J, Seifers N, Su L et al. The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J Exp Med 2005; 202: 1141\u20131151.","journal-title":"J Exp Med"},{"key":"BFleu2013196_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.coi.2007.02.004","volume":"19","author":"HY Wang","year":"2007","unstructured":"Wang HY, Wang RF . Regulatory T cells and cancer. Curr Opin Immunol 2007; 19: 217\u2013223.","journal-title":"Curr Opin Immunol"},{"key":"BFleu2013196_CR45","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.1182\/blood-2011-10-386482","volume":"119","author":"X Yao","year":"2012","unstructured":"Yao X, Ahmadzadeh M, Lu YC, Liewehr DJ, Dudley ME, Liu F et al. Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer. Blood 2012; 119: 5688\u20135696.","journal-title":"Blood"},{"key":"BFleu2013196_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2009.08.041","volume":"209","author":"ET van","year":"2010","unstructured":"van ET, van Puijvelde GH, Foks AC, Habets KL, Bot I, Gilboa E et al. Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis. Atherosclerosis 2010; 209: 74\u201380.","journal-title":"Atherosclerosis"},{"key":"BFleu2013196_CR47","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1080\/10428190802064917","volume":"49","author":"E Capriotti","year":"2008","unstructured":"Capriotti E, Vonderheid EC, Thoburn CJ, Wasik MA, Bahler DW, Hess AD . Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma. Leuk Lymphoma 2008; 49: 1190\u20131201.","journal-title":"Leuk Lymphoma"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2013196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2013196","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2013196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T19:38:58Z","timestamp":1688326738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2013196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,1]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["BFleu2013196"],"URL":"https:\/\/doi.org\/10.1038\/leu.2013.196","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,1]]},"assertion":[{"value":"17 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}